Black Diamond Therapeutics, Inc. · NASDAQ:BDTX
T. Rowe Price Investment Management, Inc. reported a 7.00% stake in Black Diamond Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 8, 2026
T. Rowe Price Investment Management, Inc. reported a 7.00% stake in Black Diamond Therapeutics, Inc., 4,028,202 shares, as a passive investor on Jun 30, 2026. Filed Jul 8, 2026 (Schedule 13G/A).
- Stake
- 7.00%
- Shares
- 4,028,202
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 7.00% | 4,028,202 |
Source
Related
- Black Diamond Therapeutics, Inc.
- T. Rowe Price Investment Management, Inc.
- Black Diamond Therapeutics, Inc. shareholders
- Form 4 · Behbahani Ali · Sep 21, 2026
- Form 4 · Raman Prakash · Sep 21, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Behbahani Ali · Jun 22, 2026
- Form 4 · Raman Prakash · Jun 22, 2026